Home > News > First US company set for DIFX listing
February 4th, 2008
First US company set for DIFX listing
Abstract:
NanoDynamics will become the first US company to list on the DIFX, with its debut initial public offering (IPO) priced at $11 per share, said co-lead managers Daman and its US strategic partner, Global Crown Capital.
NanoDynamics is a US-based global alternative energy and clean technology company utilising nanotechnology-based advanced materials to develop solutions to some of the world's most urgent challenges in the energy, environment, water and infrastructure markets.
'The intent of this IPO is to place 9,100,000 shares at a filing price of $11 to raise $100 million. The trading symbol for NanoDynamics will be "NDMX',' Shehab Gargash, Group CEO of Daman said.
'The listing is scheduled for February 11 and approximately half of the participants will be US institutional investors, while the other half will comprise regional Middle East institutions and accredited investors,' he added.
Source:
.tradearabia.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||